| 1 |
33137694 | Effects of selective calcium channel blockers on ions' permeation through the human Cav1.2 ion channel: A computational study. | 2021 Jan |
1 |
| 2 |
33219601 | Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease. | 2021 Feb |
1 |
| 3 |
32308799 | 4-Pyridinio-1,4-Dihydropyridines as Calcium Ion Transport Modulators: Antagonist, Agonist, and Dual Action. | 2020 |
1 |
| 4 |
31735158 | 1,4-Dihydropyridine: A Dependable Heterocyclic Ring with the Promising and the Most Anticipable Therapeutic Effects. | 2019 |
2 |
| 5 |
17011717 | Revival of nifedipine, a dihydropyridine-based calcium blocker. | 2007 |
1 |
| 6 |
15661163 | Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. | 2005 Feb 5 |
3 |
| 7 |
16425978 | Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells. | 2005 |
1 |
| 8 |
1658191 | Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium. | 1991 Jul |
2 |
| 9 |
1695946 | Dihydropyridine actions on calcium currents of frog sympathetic neurons. | 1990 Jul |
3 |